IRIS
MARCHESE, ANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 41.050
AS - Asia 4.485
NA - Nord America 2.176
SA - Sud America 325
AF - Africa 90
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 48.132
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 40.256
US - Stati Uniti d'America 2.055
SG - Singapore 2.028
CN - Cina 1.122
VN - Vietnam 714
FR - Francia 400
BR - Brasile 206
BD - Bangladesh 173
HK - Hong Kong 155
FI - Finlandia 107
DE - Germania 73
AR - Argentina 52
CA - Canada 48
MX - Messico 47
JP - Giappone 45
GB - Regno Unito 41
IN - India 36
IQ - Iraq 36
CH - Svizzera 34
NL - Olanda 31
ID - Indonesia 30
ZA - Sudafrica 21
RU - Federazione Russa 18
TH - Thailandia 16
EC - Ecuador 15
PH - Filippine 13
UZ - Uzbekistan 13
MA - Marocco 12
MY - Malesia 12
VE - Venezuela 12
ES - Italia 11
IE - Irlanda 11
CO - Colombia 10
DZ - Algeria 10
EG - Egitto 10
KR - Corea 10
PY - Paraguay 10
SA - Arabia Saudita 10
PK - Pakistan 9
CL - Cile 8
KE - Kenya 8
UA - Ucraina 8
JO - Giordania 7
PL - Polonia 7
SE - Svezia 7
TR - Turchia 7
AZ - Azerbaigian 6
CR - Costa Rica 6
ET - Etiopia 6
KZ - Kazakistan 6
PE - Perù 6
SK - Slovacchia (Repubblica Slovacca) 6
AE - Emirati Arabi Uniti 5
BG - Bulgaria 5
JM - Giamaica 5
OM - Oman 5
UY - Uruguay 5
BH - Bahrain 4
HU - Ungheria 4
TW - Taiwan 4
AO - Angola 3
AU - Australia 3
GT - Guatemala 3
HN - Honduras 3
HR - Croazia 3
LT - Lituania 3
LY - Libia 3
MD - Moldavia 3
NP - Nepal 3
PT - Portogallo 3
RE - Reunion 3
RO - Romania 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AT - Austria 2
BE - Belgio 2
CG - Congo 2
DO - Repubblica Dominicana 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NI - Nicaragua 2
PS - Palestinian Territory 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AL - Albania 1
BB - Barbados 1
BF - Burkina Faso 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CM - Camerun 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
IL - Israele 1
IR - Iran 1
KG - Kirghizistan 1
KH - Cambogia 1
Totale 48.117
Salva come PNG Salva come JPEG
Città #
Genova 23.538
Genoa 9.408
Rapallo 4.270
Vado Ligure 2.599
Singapore 982
San Jose 786
Lauterbourg 372
Ho Chi Minh City 227
New York 191
Ashburn 190
Hanoi 157
Hong Kong 147
Beijing 143
Helsinki 104
Bordighera 96
Santa Clara 85
Frankfurt am Main 57
Council Bluffs 43
Tokyo 39
Los Angeles 35
Rome 35
Zurich 34
Mexico City 30
Haiphong 29
Milan 28
Da Nang 27
Amsterdam 24
Buffalo 22
Orem 22
Tianjin 22
São Paulo 21
Dallas 18
Naples 18
Chicago 17
Biên Hòa 16
Baghdad 14
Hải Dương 13
Johannesburg 13
Boardman 12
Bologna 12
Denver 12
Guangzhou 12
Dublin 11
Houston 11
London 10
San Francisco 10
Dhaka 9
Florence 9
Palermo 9
Shenzhen 9
Cardiff 8
Des Moines 8
Nuremberg 8
Phoenix 8
Quảng Ngãi 8
Shanghai 8
Amman 7
Atlanta 7
City of London 7
Miami 7
Montreal 7
Mumbai 7
Nairobi 7
Tashkent 7
Can Tho 6
Curitiba 6
Nha Trang 6
Poplar 6
Rio de Janeiro 6
Thái Nguyên 6
Turin 6
Vĩnh Long 6
Warsaw 6
Addis Ababa 5
Asunción 5
Baku 5
Bangkok 5
Bari 5
Bratislava 5
Brooklyn 5
Buenos Aires 5
Bắc Ninh 5
Chennai 5
Jakarta 5
Kingston 5
Long Xuyen 5
Mosul 5
Ninh Bình 5
Porto Alegre 5
Riyadh 5
San José 5
Stockholm 5
The Bronx 5
Thái Bình 5
Toronto 5
Catania 4
Córdoba 4
Dubai 4
Guayaquil 4
Istanbul 4
Totale 44.286
Salva come PNG Salva come JPEG
Nome #
Confronto tra gli effeti dei mucolitici N-acetilcisteina, ambroxol, bromexina e sobrerolo sulla sintesi e sulla degradazione di biofilm di Staphylococcus aureus. 1.777
Potentially human pathogenic vibrios in marine and fresh bathing waters related to environmental conditions and disease outcome 270
Emergence of a KPC-3-Producing Escherichia coli ST69 as a Cause of Bloodstream Infections in Italy 232
Population pharmacokinetics and probability of target attainment of meropenem in critically ill patients 228
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 225
Infections caused by KPC-producing Klebsiella pneumoniae: Differences in therapy and mortality in a multicentre study 221
Meropenem for treating KPC-producing Klebsiella pneumoniae bloodstream infections: should we get to the PK/PD root of the paradox? 221
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 204
Analysis of clinical management of infected breast implants and of factors associated to successful breast pocket salvage in infections occurring after breast reconstruction 202
. In vitro activity of fosfomycin against Gram-negative urinary pathogens and the biological cost of fosfomycin resistance 197
Epidemiological study of pathogens isolated from blood in Liguria during 2011. 194
DNA bacterial load in children with bacteremic pneumococcal community-acquired pneumonia. 194
A Fatal Case of Nosocomial Legionnaires' Disease: Implications From an Extensive Environmental Investigation and Isolation of the Bacterium From Blood Culture. 193
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after open heart surgery 191
Antibiotic susceptibility patterns and serotypes of antibiotic resistant and or invasive Streptococcus pneumoniae strains circulating in Italy 188
. Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 187
Antimicrobial activity of eugenol and essential oils containing eugenol: A mechanistic viewpoint 186
Efficacy of N-acetyl-cysteine in combination with thiamphenicol in sequential (intramuscular/aerosol) therapy of upper respiratory tract infections even when sustained by bacterial biofilms 185
Active surveillance of Streptococcus pneumoniae bacteremia in Italian children 183
Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients. 181
Activity of moxifloxacin on biofilms produced in vitro by bacterial pathogens involved in acute exacerbations of chronic bronchitis 180
Antibacterial activity of polyphenols. 179
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 177
Bordetella holmesii endocarditis in a patient with systemic lupus erythematous treated with immunosuppressive agents. 176
Activity of Bay 12-8039 against well-characterised antibiotic resistant S.pyogenes. 175
Antistaphylococcal activity of cefdinir, a new oral third-generation cephalosporin, alone and in combination with other antibiotics, at supra- and sub-MIC levels. 175
Bloodstream infections in critically ill patients with COVID-19 175
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 173
Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp. 172
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 170
Previous bloodstream infections due to other pathogens as predictors of carbapenem-resistant Klebsiella pneumoniae bacteraemia in colonized patients: results from a retrospective multicentre study 170
Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital. 169
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 167
Breast implant infection due to Paenibacillus residui in a cancer patient 165
Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection 165
In vitro antimicrobial activity of tigecycline against Gram-negative and Gram-positive pathogens collected in Northen Italy (T.E.S.T. program 2010). 164
Early carbapenem-resistant Klebsiella pneumoniae bacteraemia: should we expand the screening? 164
Phytochemicals for human disease: An update on plant-derived compounds antibacterial activity 164
Adesione batterica e fungina a materiali protesici del cavo orale. 163
Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting 162
Clinical and Microbiological Characterization of Late Breast Implant Infections after Reconstructive Breast Cancer Surgery 162
Influence of in vitro simulated gastroduodenal digestion on the antibacterial activity, metabolic profiling and polyphenols content of green tea (Camellia sinensis). 160
Epidemiology of multi-resistance Gram negative pathogen circulating in Liguria and molecular characterization of different carbapenemases. 159
Antibiotic susceptibility and serotype distribution in Streptococcus pneumoniae circulating in Italy: results of the SEMPRE surveillance study (2000-2002). 159
Plasmid loss from gram-negative bacteria exposed to subinhibitory concentrations of beta-lactam drugs and azithromycin. 157
Activity of Teicoplanin, Vancomycin and 8 Other Drugs Against Gram-Positive Pathogens Isolated in Italy 157
The Susceptibility of Candida albicans to Gamma-Radiations and Ketoco-nazole Depends on Transitional Filamentation. 157
Characterization of Fluoroquinolone-Resistant Escherichia coli Causing Septicemic Colibacillosis in Calves in Italy: Emergence of a Multiresistant O78 Clonal Group. 156
Does the adoption of EUCAST susceptibility breackpoints affects the selection of antimicrobials to treat acute community-acquired respiratory tract infections? 156
Alteration of Membrane Permeability of Bacteria and Yeast by High Frequency Alternating Current (HFAC). 155
Antimicrobial susceptibility profiles of Pseudomonas aeruginosa and Staphylococcus aureus isolated in Italy from patients with hospital-acquired infections. 155
Antibiotic persistence: the role of spontaneous DNA repair response 154
Post antibiotic effect and delay of regrowth in strains carrying mutations that save proteins or RNA 153
The role of macrolides in Streptococcus pyogenes pharyngitis. 151
A new in vitro model system to study antimycotic drugs. 150
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 149
Antistaphylococcal activity and metabolite profiling of manuka honey (Leptospermum scoparium L.) after in vitro simulated digestion 148
Risk factors for infections due to carbapenem-resistant Klebsiella pneumoniae after cardiac surgery 148
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 148
Predictive Models for Identification of Hospitalized Patients Harboring KPC-Producing Klebsiella pneumoniae. 147
Macrolide resistance mechanisms and expression of phenotypes among Streptococcus pneumoniae circulating in Italy 146
Tigecycline in vitro activity against gram-negative and gram-positive pathogens collected in Italy. 146
Antibiotic resistance among S.pneumoniae isolated in Italy. 145
Hypoalbuminemia as a predictor of acute kidney injury during colistin treatment 145
Antifungal resistance in Candida spp. isolated in Italy between 2002 and 2005 from children and adults 144
Pharmacokinetics of high-dose extended-infusion meropenem during pulmonary exacerbation in adult cystic fibrosis patients: a case series 144
Resistance patterns of lower respiratory tract pathogens in Europe. 143
Epidemiological study of pathogens isolated from blood in Liguria (January-April 2010). 143
Enhanced biofilm-production in pathogens isolated from patients with rare metabolic disorders 142
European survey of glycopeptide susceptibility: Staphylococcus spp. 142
In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance 142
Antibiotic susceptibility patterns and serotypes of nasopharyngeal Streptococcus pneumoniae circulating in healthy italian children. 141
Attività antibatterica di N-acetilcisteina sui principali patogeni responsabili di infezioni delle alte vie respiratorie e sui germi del cavo orale. 141
Detection of macrolide resistance genes in Streptococcus pneumoniae using a rapid method 140
Antibiotic susceptibility tests directly on urine samples using Uro-Quick, a rapid automated system 140
AmpC-type plasmid mediated beta-lactamase in Klebsiella oxytoca e K.pneumoniae. 140
Activity of levofloxacin on contemporary respiratory pathogens 139
F'lac integrative suppression in gyrB(Ts) mutan 139
In vitro activity of quinupristin/dalfopristin against selected bacterial pathogens isolated in Italy 138
Activity of moxifloxacin (Bay 12-8039) against erythromycin-resistant Streptococcus pyogenes. 138
Predictors of Mortality in Bloodstream Infections Caused by KPC-Producing Klebsiella pneumoniae: Importance of Combination Therapy. 138
Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: Results from a multicenter case-control-control study 138
Interazione sinergica di teicoplanina e vancomicina con ceftazidime e azitromicina nei confronti di Pseudomonas aeruginosa. 137
First report of chronic pulmonary infection by KPC-3-producing and colistin-resistant Klebsiella pneumoniae sequence type 258 (ST258) in an adult patient with cystic fibrosis 137
Epidemiology and outcome of Klebsiellapneumoniae carbapenemase-producing Klebsiella pneumoniae (KPC-KP) infections in cardiac surgery patients: a brief narrative review 137
Microbiological rationale for the utilisation of prulifloxacin, a new fluoroquinolone, in the eradication of serious infections caused by Pseudomonas aeruginosa. 136
Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Escherichia coli in Italy. 136
The oxazolidinones as a new family of antimicrobial agent. 135
Antibiotic persistence: the role of spontaneous DNA repair. 134
Effects of rifaximin on bacterial virulence mechanisms at supra- and sub-inhibitory concentrations 134
In vitro interaction between ceftazidime and vancomycin/teicoplanin in the presence of azithromycin against Pseudomonas aeruginosa. 134
Antimicrobial activity of algae extracts against bacteria isolated from ear swabs. 134
European emergence of ciprofloxacin-resistant Escherichia coli clonal groups O25:H4-ST 131 and O15:K52:H1 causing community-acquired uncomplicated cystitis. 133
Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typing. 133
A pain in the back: anaerobic vertebral spondylitis of hematogenous origin 133
Isolation of Candida auris from invasive and noninvasive samples of a patient suffering from vascular disease, Italy, July 2019 133
Epidemiology of resistance to antimicrobial drugs in the major respiratory pathogens circulating in Europe. 132
The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections 131
Pleiotropic effect of sodium arsenite on Escherichia coli 131
Indagine sulla diffusione di stafilococchi resistenti alla meticillina in Liguria 131
Totale 17.670
Salva come PNG Salva come JPEG
Categoria #
all - tutte 146.674
article - articoli 94.893
book - libri 0
conference - conferenze 51.494
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 287
Totale 293.348
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021121 0 0 0 0 0 0 0 0 0 0 0 121
2021/20224.798 101 376 209 603 278 264 426 1.144 158 449 139 651
2022/20235.162 535 275 125 478 789 976 47 452 902 81 431 71
2023/20242.365 133 355 74 217 213 461 123 157 120 69 114 329
2024/20256.083 190 578 246 425 781 568 564 785 323 366 512 745
2025/202611.044 1.178 469 524 824 1.388 1.285 1.842 597 842 1.146 669 280
Totale 48.367